TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15096 · Aug 26

#lua#layout#lua#neovim#neovim_plugin#neovim_ui#nvim#plugin#scratchpad#ui#ux#zen_mode#zenmode The no-neck-pain.nvim plugin for Neovim centers your active editing window by adding empty buffers on each side, creating padding that keeps your focus in the middle of the screen. It works right away without setup, supports multiple tabs, split windows, and integrates with popular file tree and dashboard plugins. You can customize its width, colors, and behavior, and even use the side buffers as scratchpads for notes. This helps reduce neck strain and improves focus, especially on wide monitors, by keeping your code or text centered and easy to read without distractions. https://github.com/shortcuts/no-neck-pain.nvim

Results

1 similar post found

Search: #floodbase

当前筛选 #floodbase清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #4251 · 02/26/2025, 01:00 PM

Recent Funding Rounds Overview 🔍Funding Highlights: - Edera: $15M on Feb 25, 2025. Secure products launch. Learn more - Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more - Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more - Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more - Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more - Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more - BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more - Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more - QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more - Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more #Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement